Insider buying last 90 days
No open-market insider purchases were filed for XYL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every XYL insider filing, plotted on the chart in Gekko.Open XYL in Gekko
Gekko Brief
AI summaryXylem shares fell this week on concerns over new financing tied to its planned acquisition of Cornell Pump and Roper Pump businesses, with the stock dropping as much as 5.51% to $102.66 and touching a 52-week low of $105.19 amid balance-sheet worries. The decline also coincided with a broader selloff in industrial names as the 10-year Treasury yield jumped to 5.14%. Separate commentary pointed to a discounted cash flow analysis suggesting the stock could be 35% undervalued, alongside notes on continued strength in Water Solutions and Services, Applied Water, and Measurement & Control Solutions segments.
The stock closed at $100.91, down 1.7%, sitting below both its 50-day average of $113.52 and 200-day average of $121.74, with the 50-day itself below the 200-day. Trailing returns are negative across the past month, three months, six months and year. The GekkoIndex reads 72.7, placing Xylem in the Buying zone, while the price sits 26.5% below Gekko Fair Value of $137.31.
Xylem's next earnings report is set for 3 November 2026, before the open, 35 days out and beyond a typical 20-trading-day holding window. Its last report showed adjusted EPS of $1.46 against an estimate of $1.34, with a 1.6% reaction. Over the last 90 days, Congress recorded 1 buy and 0 sells. Seasonally, the next 20 trading days have averaged a 2.4% return over 5 years, higher in 3 of them.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Xylem price vs fair value
Close $100.91200-day averageGekko Fair Value $137.31
Xylem quick facts
- Market cap
- $23.57B
- P/E ratio
- 25.9
- Forward P/E
- 17.4
- EPS, TTM
- $3.97
- Revenue, TTM
- $9.13B
- Profit margin
- 11.2%
- Dividend yield
- 1.53%
- Beta
- 1.00
- Volume
- 2.05M avg 2.74M
- 1-year return
- −28.7%
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±5%
- 50-day average
- $113.52
- 200-day average
- $121.74
- Next earnings
- Nov 3 before open
- Shares outstanding
- 233.5M
Xylem swing-trade checklist
Xylem scores 5 supportive, 0 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
5 supportive0 mixed1 headwind
- Trendheadwind
Below 50 and 200-day
Close $100.91 is below the 50-day ($113.52) and 200-day ($121.74) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
72.7, Buying
Reading 72.7 is in the Buying zone.
See the GekkoIndex - Fair valuesupportive
26.5% below
Price is 26.5% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneysupportive
Leans bullish
Last 90 days: Congress 1 buy / 0 sales.
See smart money - Earnings risksupportive
Reports in 35 days
Next report Nov 3, 2026, 35 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+2.4% on average
From this point in the calendar, the next 20 trading days averaged +2.4% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Xylem stock chart and price history
Xylem closed at $100.91 on Sep 28, 2026, −28.7% over the past year, inside a 52-week range of $100.90 to $154.27.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −10.4%
- 3 months
- −13.6%
- 6 months
- −14.2%
- 1 year
- −28.7%
The full XYL chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open XYL in Gekko
Follow Xylem through every session
Put XYL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track XYL in GekkoFree for 7 days. No credit card required.
About Xylem
Xylem designs, manufactures, and services engineered equipment and systems that move, treat, and monitor water for utilities, industrial operators, and residential and commercial building customers around the world. It is widely recognized for its pumps, controls, and treatment equipment sold under brand names such as Flygt, Goulds Water Technology, Sensus, and Wedeco, which serve tasks ranging from moving wastewater to filtering and disinfecting water supplies.
The company is structured into segments covering water infrastructure, applied water systems, measurement and control solutions, and broader water services. Its offerings span physical hardware like pumps, valves, and heat exchangers to smart meters, sensors, software, and cloud-based data analytics, along with maintenance, emergency response, dewatering, and municipal services such as odor control and asset condition monitoring. Customers include utilities, industrial facilities, and residential and commercial building operators that rely on these tools for water-related infrastructure needs.
Xylem is headquartered in Washington, District of Columbia. It traces back to an entity formerly called ITT WCO, Inc., which was renamed Xylem in July 2011 and incorporated that same year. Its shares are listed on the NYSE under the ticker XYL.
- Listed
- NYSE
- Sector
- Producer manufacturing
- Industry
- Industrial machinery
- Website
- xylem.com
Xylem GekkoIndex: the smart money zone
Xylem’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 72.7, in the Buying zone, up 5.1 points over five sessions.
72.7Buying
Up 5.1 points over five sessions, from the Accumulation zone.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying (current zone) | 26 | +1.5% | +5.2% | ||
| Accumulation | 231 | −0.3% | +0.1% | ||
| Neutral | 365 | 0.0% | −0.5% | ||
| Distribution | 48 | +0.6% | +0.3% | ||
| Selling | 2 | Too few readings yet | |||
Average XYL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Buying readings averaged +3.2% over 20 days. Past behaviour doesn’t guarantee future results.
Buying zone: Smart money likely accumulating heavily. About the five zones →
See every daily GekkoIndex reading plotted over the XYL price, zone by zone.Track XYL in Gekko
Is Xylem stock overvalued? Gekko Fair Value
Xylem trades 26.5% below Gekko Fair Value of $137.31, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Xylem shares are worth, recalculated every trading day.
$137.31
Gekko Fair Value, Sep 26, 2026
26.5% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open XYL in Gekko
Xylem insider and Congress trading
No open-market insider purchases were filed for Xylem, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
1trade disclosed: 1 purchase and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Aug 12 traded Jul 7 |
From congressional disclosures, which report amounts as ranges.
Buybacks
Xylem has been buying back its own shares.
- Latest authorization
- $1.50B, Feb 25, 2026
- Bought back, quarter ended Jun 30, 2026
- $680.0M
- As a share of market cap
- 2.89%
- Trailing four quarters
- $1.25B
From company filings.
Hedge funds and billionaires quarter ended Sep 30
0of the funds Gekko tracks hold XYL.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Xylem earnings: next date and track record
Xylem reports on Nov 3, 2026, before the open (35 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 3, 2026
Expected before the open, 35 days away
- EPS estimate
- $1.47
- Revenue estimate
- $2.29B
7 of 8reports beat the EPS estimate
±5.9%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 28, 2026 AI summary
- What they said
- Xylem reported solid Q2 2026 results with modest revenue growth (up 1% organic), record adjusted EPS of $1.46 (+16% YoY), improved EBITDA margin (23.3%, +150 bps YoY), and a strong backlog of $5.3 billion with book-to-bill above 1. Performance was supported by strength in Water Infrastructure, WSS (Water Solutions & Services) and Applied Water (notably data centers). Headwinds included a 27% decline in China revenue, near-term pushouts in electric metering (MCS) tied to affordability and election-related caution, and ~2% walkaway revenue from 80/20 optimization. Management emphasized strategic positioning following the Evoqua acquisition, growth opportunities from AI/semiconductor/power sectors, outsourcer contracts (build-own-operate), digital offerings (Vue/data lake), and a disciplined capital allocation approach including opportunistic buybacks and a targeted ~$1B annual M&A deployment. Supply chain monitoring (rare earths, chips) and continued 80/20 actions were highlighted.
- Guidance
- Management provided forward commentary: revenue progression of roughly flat Q1, +1% Q2, ~+3% Q3, and exiting the year at mid-single-digit organic growth in Q4. They expect positive book-to-bill in the second half with high-single-digit orders growth in the water side and mid-single-digit growth in Water Infrastructure in the back half. MCS margins: Q3 expected up 30-80 bps (company referenced Q2 margin improvement of 150 bps). Data center revenue expected ~200% growth year-over-year and to represent roughly 2% of revenue by year-end. Company reiterated plan to deploy approximately $1 billion of capital for M&A annually and noted opportunistic share repurchases in the quarter.
- Risks flagged
- Headwinds discussed include significant China revenue and order declines (~27-30%), project pushouts in electric metering driven by affordability and election-related caution, near-term walkaway revenue (~2%) from 80/20 portfolio optimization, supply chain risks for chips and rare earths (management is building safety stock), and lumpy nature of WSS and outsourced water opportunities. Management also flagged competitive pressure in some markets and macro uncertainty that could affect near-term investment by customers.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 28, 2026 | $1.46 est $1.34 | $2.34B est $2.34B | +1.6% |
| Apr 28, 2026 | $1.12 est $1.09 | $2.13B est $2.11B | −6.6% |
| Feb 10, 2026 | $1.42 est $1.41 | $2.40B est $2.37B | −9.6% |
| Oct 28, 2025 | $1.37 est $1.23 | $2.27B est $2.22B | +2.4% |
| Jul 31, 2025 | $1.26 est $1.15 | $2.30B est $2.21B | +8.9% |
| Apr 29, 2025 | $1.03 est $0.96 | $2.07B est $2.04B | +4.0% |
| Feb 4, 2025 | $1.18 est $1.13 | $2.26B est $2.18B | +5.7% |
| Oct 31, 2024 | $1.11 est $1.11 | $2.10B est $2.17B | −8.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Xylem stock forecast and analyst price targets
Analysts’ average 12-month price target for Xylem is $153.88, +52.5% from the last close, from 15 firms rating the stock in the last 90 days.
$153.88consensus 12-month target, +52.5% from the last close
Now $100.91Avg $153.88
Low $130High $172
Each firm’s latest rating in the last 90 days: 15 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 17 | CFRA | — | — |
| Sep 15 | Wolfe Research | — | — |
| Aug 24 | Jefferies | $150 | +48.6% |
| Aug 13 | UBS | $138 | +36.8% |
| Aug 12 | Stifel Nicolaus | $160 | +58.6% |
+5.2%average 20-day move after past Buying readings
+2.4%average move over the next 20 trading days in the last 5 years
±2.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Xylem seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Xylem averaged +2.4% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.6% | 2 of 5 |
| Next 10 trading days | −0.7% | 3 of 5 |
| Next 15 trading days | +1.0% | 3 of 5 |
| Next 20 trading days | +2.4% | 3 of 5 |
| Next 30 trading days | +7.2% | 4 of 5 |
For scale, XYL’s typical 20-trading-day move in either direction is about 5%.
Xylem market cap and key statistics
Xylem’s market cap is $23.57B, with a P/E ratio of 25.9 and revenue of $9.13B over the last twelve months.
Valuation
- Market cap
- $23.57B
- P/E ratio
- 25.9
- Forward P/E
- 17.4
- EPS, TTM
- $3.97
- Gekko Fair Value
- $137.31
Trading
- Volume
- 2.05M
- Avg volume, 20 days
- 2.74M
- 52-week high
- $154.27
- 52-week low
- $100.90
- Shares outstanding
- 233.5M
Financials
- Revenue, TTM
- $9.13B
- Profit margin
- 11.2%
- Return on equity
- 9.2%
- Quarterly earnings growth, YoY
- +19.5%
Risk and income
- Beta
- 1.00
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±5%
- Dividend yield
- 1.53%
Xylem stock news this week
Coverage of Xylem this week reads positive: 6 positive, 3 neutral and 5 negative headlines.
- Here's Why You Should Retain Xylem Stock in Your Portfolio NowTradingView, Sep 28
- Envestnet Asset Management Inc. Decreases Stake in Xylem Inc. $XYLMarketBeat, Sep 27
- Xylem (XYL) Stock Could Be 35% Undervalued As Cash Flow Holds UpYahoo Finance, Sep 26
- Xylem Inc. (XYL) stock price, news, quote and historyYahoo Finance Australia, Sep 25
- Xylem stock heads into the open after a 3.21 percent dropAD HOC NEWS, Sep 25
- Custom Truck One Source, Terex, Xylem, Onterris, and Oshkosh Shares Plummet, What You Need To KnowYahoo! Finance Canada, Sep 24
Xylem peers
Xylem’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LRCXLam Research | Neutral | 7.7% above |
| AMATApplied Materials | Neutral | 11.5% below |
| PHParker-Hannifin | Neutral | 5.9% above |
| TTTrane Technologies | Neutral | 13.7% above |
| JCIJohnson Controls International | Neutral | 11.4% above |
| CARRCarrier Global | Accumulation | 4.9% below |
A peer links to its own page where one exists.
Xylem stock FAQ
What is Xylem’s market cap?
Xylem’s market cap is $23.57B at the Sep 28, 2026 close of $100.91, with 233.5M shares outstanding. The shares trade on a P/E ratio of 25.9.
What is the Xylem stock forecast?
The consensus analyst 12-month price target for Xylem is $153.88, +52.5% from the last close. Of the 15 firms that rated the stock in the last 90 days, 10 rate it a buy, 5 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Xylem stock overvalued or undervalued?
On Gekko’s estimate Xylem is undervalued: the Sep 28, 2026 close of $100.91 is 26.5% below Gekko Fair Value of $137.31. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Xylem report earnings next?
Xylem is expected to report on Nov 3, 2026, before the market opens (35 days away). Analysts expect earnings of $1.47 per share on revenue of $2.29B. Xylem beat the earnings estimate in 7 of its last 8 reports, moving 5.9% on average across the report.
What is Xylem’s 52-week high and low?
Xylem’s 52-week high is $154.27 and its 52-week low is $100.90; it closed at $100.91 on Sep 28, 2026, −28.7% over the past year.
Is Xylem stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 5 of the 6 items with data read as supportive (gekkoindex, fair value, smart money, earnings risk and seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Xylem the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.